| Authors: |
Hwa YL; Division of Hematology, Mayo Clinic, Rochester, Minnesota., Fogaren T; Division of Hematology-Oncology, Tufts Medical Center, Boston, Massachusetts., Sams A; Division of Hematology-Oncology, Outpatient Multiple Myeloma Service, Memorial Sloan-Kettering Cancer Center, New York City, New York., Faller DV; Millennium Pharmaceuticals, Inc., Cambridge, Massachusetts, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited., Stull DM; Global Medical Affairs Oncology, Millennium Pharmaceuticals, Inc., Cambridge, Massachusetts, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited., Thuenemann S; Global Medical Affairs Oncology, Millennium Pharmaceuticals, Inc., Cambridge, Massachusetts, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited., Mendelson L; Amyloidosis Center, Boston University School of Medicine, Boston, Massachusetts. |